Glycans in Vaccine Development

Glycans are at the core of many disorders and diseases generating the chance of exploiting them for therapeutic and diagnostic purposes. There are many biochemical paths and diseases in which glycans are intricately involved. Evaluating the huge potential and the capacity that glycobiology holds, many pharma and biotech companies have already started assigning their R&D budget to it. Currently, with our drug resource fast depleting against drug resistant and mutant pathogens, glycobiology hold an intact source of new candidate drugs.

  • Glycoconjugate vaccines
  • Drug interaction in cellular networking
  • Bio-defense vaccine
  • Microbial glycobiology
  • Glycoengineering

Related Conference of Glycans in Vaccine Development

May 10-11, 2019

13th International Conference on Proteomics, Genomics and Bioinformatics

| Radisson Hotel Narita | Tokyo, Japan
May 10-11, 2019

8th Asia Pacific Glycobiology Congress

Tokyo, Japan
May 17-18, 2019

2nd International Conference on Computational Biology and Bioinformatics

| Holiday Inn Singapore Atrium | Singapore
July 11-12, 2019

8th Glycobiology World Congress

Zurich, Switzerland
May 10-11, 2019

4th International Conference on Enzymology & Molecular Biology

| Radisson Hotel Narita | Tokyo, Japan
October 07-08, 2019

4th International Conference on Molecular Biology & Nucleic Acids

Chicago, Illinois, USA

Glycans in Vaccine Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in